Gilead Sciences, Inc.+ 0.785 %

Daily Stock Price

CEO

Daniel P. O'Day


Company Symbol

GILD


Exchange

NASDAQ


Industry

Biotechnology


Information

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.


*latest update 2020-05-13

Monthly Stock Price

Financial Ratios

Institutional Holders

HolderSharesDate Reported% OutValue
Vanguard Group, Inc. (The)107,093,415Mar 30, 20208.54%8,006,303,705
Blackrock Inc.101,214,991Mar 30, 20208.07%7,566,832,727
Capital Research Global Investors95,982,319Mar 30, 20207.65%7,175,638,168
State Street Corporation56,805,210Mar 30, 20204.53%4,246,757,499
Capital International Investors56,369,657Mar 30, 20204.49%4,214,195,557
Capital World Investors46,331,318Mar 30, 20203.69%3,463,729,333
Geode Capital Management, LLC19,882,508Mar 30, 20201.59%1,486,416,298
Bank Of New York Mellon Corporation18,925,759Mar 30, 20201.51%1,414,889,742
Northern Trust Corporation15,554,923Mar 30, 20201.24%1,162,886,043
Dodge & Cox Inc15,110,961Mar 30, 20201.20%1,129,695,444

Search a Stock from the NASDAQ 100

We are redirecting you to